Hepatitis Congress Updates
Excellent survival rates reported for long-term entecavir or tenofovir therapy for chronic hepatitis patients
21.02.17
The 2016 American Association for the Study of Liver Diseases (AASLD) Liver Meeting was held November 11-15 in Boston.